Related Experiment Videos

Long-term prognosis of patients with achalasia treated by cardial dilatation therapy

Y Matsuo1, F Sugimura, A Seki

  • 1Third Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan.

Insights

Expanding bag dilatation therapy for esophageal achalasia shows a 74.2% effectiveness rate, with significant weight gain observed in many patients. Surgery is recommended for cases unresponsive to multiple dilatations.

Area of Science:

  • Gastroenterology
  • Surgical Innovation

Background:

  • Esophageal achalasia is a motility disorder characterized by impaired esophageal peristalsis and failure of the lower esophageal sphincter to relax.
  • Expanding bag dilatation therapy offers a minimally invasive approach to managing achalasia.

Purpose of the Study:

  • To evaluate the long-term prognosis of expanding bag dilatation therapy for esophageal achalasia.
  • To assess the efficacy of this treatment modality based on patient outcomes and weight changes.

Main Methods:

  • A retrospective analysis of 163 patients with esophageal achalasia treated with Matsuo pneumatic bag dilator between 1964 and 1989.
  • Assessment of therapy efficacy based on body weight changes, overall effectiveness ratings, and need for subsequent surgical intervention.

Main Results:

  • Expanding bag dilatation therapy was effective in 74.2% of cases (121/163), with significant body weight increase observed in 65.6% of patients.
  • No significant correlation was found between therapy efficacy and pre-therapy dilation grade, prior symptoms, or number of dilatations.
  • 16 cases (9.8%) were rated ineffective, with 4.3% requiring subsequent surgery.

Conclusions:

  • Expanding bag dilatation therapy provides a favorable long-term prognosis for a majority of esophageal achalasia patients.
  • Surgical intervention should be considered for patients who do not achieve satisfactory long-term results after multiple sessions of expanding bag dilatation.

Related Concept Videos